000 | 05126nam a2200709 i 4500 | ||
---|---|---|---|
001 | 20163402692 | ||
003 | CtWfDGI | ||
005 | 20201201155128.0 | ||
006 | m o d | ||
007 | cr zn||||uuuuu | ||
008 | 170403t20172017enkad ob 000 0 eng d | ||
020 |
_z9781780644394 _q(alk. paper) |
||
040 |
_aCtWfDGI _beng _erda _cCtWfDGI |
||
050 | 1 | 4 |
_aRM267 _b.A57 2017eb |
082 | 0 | 4 |
_a615.7/922 _223 |
245 | 0 | 0 |
_aAntimicrobial stewardship : _bprinciples and practice / _cedited by Kerry L. LaPlante, PharmD, FCCP, Cheston B. Cunha, MD, Haley J. Morrill, PharmD, Louis B. Rice, MD and Eleftherios Mylonakis, MD, PhD, FIDSA. |
264 | 1 |
_aWallingford, Oxfordshire, UK : _bCABI, _c2017. |
|
264 | 4 | _c�2017 | |
300 |
_a1 online resource (xvii, 431 pages) : _billustrations, charts |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
520 | 3 | _aThis book is a joint effort led by five editors, Kerry L. LaPlante, Cheston B. Cunha, Haley J. Morrill, Louis B. Rice, and Eleftherios Mylonakis, with a team of section editors and the authors, who have brought together 38 chapters that describe the principles and practice of antimicrobial stewardship, mainly with reference to the US. There are eight sections. The first provides an overview of antibiotic stewardship, and it looks at the principles and history of, clinical perspectives on, and importance of education in antimicrobial stewardship. The second, on the principles of antibiotic resistance in antibiotic stewardship, covers the mechanisms of antibiotic resistance, the roles of selection, induction, and colonization in its emergence, and its association with antibiotic usage strategies. Section III, on the role of the microbiology laboratory, considers active surveillance, the antibiogram, selective reporting, and new diagnostics. The fourth section, on infection control, reviews the epidemiology of a number of important antimicrobial-resistant organisms and discusses the role of the hospital epidemiologist in antibiotic stewardship. Section V, on the pharmacokinetic and pharmacodynamic aspects of antibiotic dosing, deals with the principles of pharmacokinetics/pharmacodynamics, the optimal use of several classes of antibiotics, and switching from intravenous to oral dosing. The sixth section, on the role of the pharmacy department, examines the role of pharmacists, formulary management, benchmarking, and stewardship interventions and technologic support for these. Section VII deals with the measurement of outcomes of stewardship programmes, and includes discussion of the guidelines and milestones, economic aspects, adverse events, and stewardship in areas of increased resistance. The final section explores antimicrobial stewardship at different practice sites, looking at how it converges with the unique populations involved. | |
504 | _aIncludes bibliographical references. | ||
505 | 0 | _aOverview of Antibiotic Stewardship -- Principles of Antibiotic Resistance in Antibiotic Stewardship -- Role of the Microbiology Laboratory in Antibiotic Stewardship -- Infection Control Aspects of Antibiotic Stewardship -- Pharmacokinetic and Pharmacodynamic Aspects of Antibiotic Dosing in Antibiotic Stewardship -- Role of the Pharmacy Department in Antibiotic Stewardship -- Measuring Outcomes in Antibiotic Stewardship Programs -- Antimicrobial Stewardship and Various Practice Sites. | |
506 | _aAccess limited to subscribing institution. | ||
530 | _aAlso available in print format. | ||
588 | _aTitle from PDF title page (viewed April 3, 2017). | ||
650 | 0 | _aAntibiotics. | |
650 | 0 | _aDrug resistance in microorganisms. | |
650 | 1 | 2 |
_aAnti-Bacterial Agents _xadministration & dosage |
650 | 2 | 2 | _aDrug Resistance, Microbial |
650 | 2 | 2 |
_aInappropriate Prescribing _xprevention & control |
650 | 7 |
_aAntibiotics. _2cabt |
|
650 | 7 |
_aAntiinfective agents. _2cabt |
|
650 | 7 |
_aDiagnosis. _2cabt |
|
650 | 7 |
_aDrug resistance. _2cabt |
|
650 | 7 |
_aDrug therapy. _2cabt |
|
650 | 7 |
_aEconomic analysis. _2cabt |
|
650 | 7 |
_aEducation. _2cabt |
|
650 | 7 |
_aEpidemiology. _2cabt |
|
650 | 7 |
_aGuidelines. _2cabt |
|
650 | 7 |
_aHealth care. _2cabt |
|
650 | 7 |
_aHealth programmes. _2cabt |
|
650 | 7 |
_aHospitals. _2cabt |
|
650 | 7 |
_aHuman diseases. _2cabt |
|
650 | 7 |
_aInfection control. _2cabt |
|
650 | 7 |
_aInfectious diseases. _2cabt |
|
650 | 7 |
_aMicrobiology. _2cabt |
|
650 | 7 |
_aPharmacodynamics. _2cabt |
|
650 | 7 |
_aPharmacokinetics. _2cabt |
|
650 | 7 |
_aPharmacology. _2cabt |
|
650 | 7 |
_aPharmacy. _2cabt |
|
700 | 1 |
_aLaPlante, Kerry, _eeditor. |
|
700 | 1 |
_aCunha, Cheston B., _eeditor. |
|
700 | 1 |
_aMorrill, Haley J., _eeditor. |
|
700 | 1 |
_aRice, Louis B., _eeditor. |
|
700 | 1 |
_aMylonakis, Eleftherios, _eeditor. |
|
710 | 2 |
_aC.A.B. International, _eissuing body. |
|
776 | 0 | 8 |
_iPrint version: _tAntimicrobial stewardship. _dWallingford, Oxfordshire ; Boston, MA : CABI, [2017] _z9781780644394 (alk. paper) _w(DLC)2016022765 |
856 | 4 | 0 |
_uhttps://dx.doi.org/10.1079/9781780644394.0000 _zClick here to access resource |
942 | _cEB | ||
999 |
_c312586 _d312586 |